SNP	CH	Position (b37)	Effect allele	Other allele	EAF cases	EAF controls	Odds ratio (95% CI)	Beta	SE	P	MACH-Rsq	Nearby genes (+/− 100 kb)
rs6717024	2	144,308,780	C	G	0.2	0.18	1.133 (1.111–1.156)	0.125	0.01	1.22E-34	1	ARHGAP15
rs4333882	1	234,352,899	G	A	0.2	0.19	1.081 (1.060–1.103)	0.078	0.01	2.14E-14	0.97	MIR4671, SLC35F3
rs7609897	3	15,502,681	T	G	0.2	0.21	0.925 (0.907–0.943)	-0.078	0.01	9.76E-14	0.91	COLQ, EAF1, HACL1, METTL6, MIR4270
rs760364725	19	38,757,315	CA	C	0.49	0.48	1.062 (1.045–1.079)	0.06	0.008	5.59E-13	0.94	C19orf33, CATSPERG, DPF1, KCNK6, PPP1R14A, SIPA1L3, SPINT2, YIF1B
rs61823192	1	219,294,570	T	C	0.026	0.03	0.828 (0.785–0.873)	-0.189	0.027	1.26E-12	0.9	LYPLAL1, LYPLAL1-DT
rs1802575	2	56,093,204	C	G	0.14	0.13	1.081 (1.056–1.107)	0.078	0.012	1.56E-11	1	EFEMP1, MIR217HG
rs11428277	10	101,425,013	G	GA	0.19	0.18	1.075 (1.052–1.098)	0.072	0.011	1.69E-11	0.91	COX15, CUTC, ENTPD7, SLC25A28
rs570640158	6	32,517,793	C	T	0.27	0.26	1.070 (1.050–1.092)	0.068	0.01	2.13E-11	0.81	HLA-DQA1, HLA-DRB1, HLA-DRB5, HLA-DRB6
rs4782673	16	84,884,072	T	G	0.28	0.3	0.945 (0.928–0.961)	-0.057	0.009	1.37E-10	1	CRISPLD2, USP10
rs7464710	8	120,624,386	G	C	0.25	0.26	0.943 (0.926–0.959)	-0.059	0.009	4.13E-10	0.98	ENPP2
rs2049865	8	116,588,546	C	A	0.41	0.42	0.950 (0.935–0.965)	-0.051	0.008	4.67E-10	0.98	TRPS1
rs61817723	1	151,920,865	A	G	0.27	0.28	0.945 (0.928–0.961)	-0.057	0.009	4.71E-10	0.99	C2CD4D-AS1, NBPF18P, S100A10, S100A11, THEM4, THEM5
rs2276068	11	70,007,484	C	G	0.49	0.48	1.050 (1.034–1.067)	0.049	0.008	1.04E-09	1	ANO1, FADD, LINC02584, LOC101928443
rs9372625	6	98,344,031	A	G	0.37	0.38	0.951 (0.936–0.966)	-0.05	0.008	2.02E-09	0.99	
rs2280028	16	86,233,413	A	G	0.13	0.14	0.932 (0.911–0.955)	-0.07	0.012	3.23E-09	0.99	LINC01081, LINC01082, LINC02135
rs71472433	15	40,649,609	C	A	0.17	0.17	1.064 (1.041–1.087)	0.062	0.011	5.24E-09	0.99	ANKRD63, BAHD1, BUB1B-PAK6, CCDC9B, DISP2, INAFM2, IVD, KNSTRN, PAK6, PHGR1, PLCB2
rs2973068	5	37,778,273	G	C	0.24	0.25	0.947 (0.931–0.964)	-0.054	0.009	8.15E-09	0.99	GDNF, GDNF-AS1, WDR70
rs1888693	10	18,440,444	A	G	0.33	0.34	0.952 (0.936–0.969)	-0.049	0.009	1.14E-08	1	CACNB2
rs3732760	3	151,074,941	C	A	0.38	0.37	1.048 (1.032–1.065)	0.047	0.008	1.17E-08	1	GPR87, IGSF10, MED12L, P2RY12, P2RY13, P2RY14
rs575909118	11	15,065,235	CT	C	0.27	0.27	1.053 (1.035–1.072)	0.052	0.009	1.40E-08	0.98	CALCA, CALCB, INSC
rs11030119	11	27,728,102	A	G	0.3	0.31	0.951 (0.935–0.968)	-0.05	0.009	1.44E-08	1	BDNF, BDNF-AS, LINC00678
rs60731259	7	73,439,465	CA	C	0.066	0.061	1.096 (1.063–1.131)	0.092	0.016	1.96E-08	0.99	ELN, LIMK1
rs9411377	9	136,145,404	A	C	0.28	0.29	0.950 (0.934–0.967)	-0.051	0.009	2.01E-08	0.96	MED22, OBP2B, RPL7A, SNORD24, SNORD36A, SNORD36B, SNORD36C, STKLD1, SURF1, SURF2, SURF4, SURF6
rs377411728	18	6,305,754	T	C	0.00071	0.00031	2.641 (1.878–3.714)	0.971	0.174	2.42E-08	0.83	L3MBTL4, L3MBTL4-AS1, MIR4317
rs115809651	4	162,414,623	A	G	0.0014	0.00046	3.525 (2.359–5.269)	1.26	0.205	8.07E-10	0.86	FSTL5
rs138491114	22	47,432,980	A	G	0.0035	0.0018	1.986 (1.557–2.532)	0.686	0.124	3.14E-08	0.97	TBC1D22A
rs772878892	16	49,404,415	G	A	0.0011	0.00032	3.597 (2.274–5.690)	1.28	0.234	4.77E-08	0.9	C16orf78, CBLN1
rs143977447	5	164,646,152	A	C	0.011	0.0053	2.375 (1.787–3.156)	0.865	0.145	2.20E-09	0.85	
rs547484470	7	68,931,296	A	C	0.0045	0.0014	3.710 (2.396–5.744)	1.311	0.223	4.13E-09	0.88	
rs116879283	7	52,434,143	C	T	0.017	0.0063	2.956 (2.033–4.299)	1.084	0.191	1.49E-08	0.9	
rs564399474	13	54,865,197	G	A	0.016	0.0039	4.527 (2.930–6.994)	1.51	0.222	1.02E-11	0.93
rs182592259	14	96,788,318	A	T	0.016	0.005	3.589 (2.323–5.546)	1.278	0.222	8.73E-09	0.88	AK7, ATG2B, BDKRB1, BDKRB2, GSKIP
rs139809494	17	79,796,214	T	C	0.019	0.0064	3.139 (2.117–4.655)	1.144	0.201	1.30E-08	0.96	ALYREF, ANAPC11, ARHGDIA, GCGR, MAFG, MAFG-DT, MCRIP1, NPB, P4HB, PCYT2, PPP1R27, PYCR1, SIRT7
rs2181386	14	94,039,907	G	A	0.16	0.12	1.490 (1.294–1.716)	0.399	0.072	3.51E-08	1	UNC79
rs28752520	6	32,584,739	C	T	0.24	0.25	0.931 (0.911–0.951)	-0.072	0.011	1.77E-10	0.99	HLA-DQA1, HLA-DQB1, HLA-DQB1-AS1, HLA-DRB1, HLA-DRB5, HLA-DRB6
rs374402947	16	89,154,513	T	C	0.0014	0.00048	3.391 (2.300–4.998)	1.221	0.198	6.86E-10	0.88	ACSF3, CDH15, LINC00304, LINC02138
rs77438700	15	78,906,637	G	A	0.064	0.074	0.839 (0.795–0.887)	-0.175	0.028	7.72E-10	0.97	CHRNA3, CHRNA5, CHRNB4, HYKK, PSMA4
rs532298826	4	138,378,079	A	T	0.0016	0.00064	3.056 (2.093–4.461)	1.117	0.193	6.62E-09	0.8	LINC02172, PCDH18
rs763947133	5	127,719,333	T	C	0.00098	0.00029	3.971 (2.466–6.393)	1.379	0.243	1.33E-08	0.81	FBN2
rs376768393	3	154,969,551	C	T	0.021	0.0064	3.850 (2.434–6.090)	1.348	0.234	8.57E-09	0.87	DWORF, LINC01487, MME
rs532825748	1	169,752,583	G	A	0.0078	0.0041	2.018 (1.586–2.568)	0.702	0.123	1.13E-08	0.89	C1orf112, METTL18, SCYL3, SELE, SELL
rs147389769	2	231,527,107	T	C	0.007	0.0036	2.130 (1.638–2.769)	0.756	0.134	1.60E-08	0.83	CAB39, LINC01907
rs564716204	4	151,664,401	T	C	0.0027	0.00092	3.353 (2.200–5.111)	1.21	0.215	1.90E-08	0.82	LRBA
rs539059490	6	122,025,326	G	T	0.0073	0.0039	2.006 (1.567–2.568)	0.696	0.126	3.65E-08	0.89	
rs62441491	7	41,892,859	A	G	0.056	0.018	3.438 (2.274–5.199)	1.235	0.211	4.73E-09	0.94	INHBA-AS1
rs6595799	5	127,408,683	C	T	0.28	0.27	1.092 (1.058–1.127)	0.088	0.016	2.39E-08	0.98	LINC01184, SLC12A2
rs568156598	7	94,453,230	G	A	0.0029	0.00091	3.747 (2.397–5.858)	1.321	0.228	6.68E-09	0.85	PPP1R9A
rs771331833	8	118,513,358	A	C	0.0013	0.00049	2.989 (2.096–4.262)	1.095	0.181	1.62E-09	0.93	MED30
rs189319388	3	7,867,797	T	C	0.0077	0.0055	1.527 (1.313–1.775)	0.423	0.077	4.63E-08	0.81	GRM7
rs192629083	7	14,037,179	T	C	0.0077	0.0025	3.702 (2.396–5.721)	1.309	0.222	3.50E-09	0.86	ETV1
rs77261774	4	60,641,124	A	G	0.034	0.02	1.788 (1.461–2.188)	0.581	0.103	1.49E-08	1	LINC02429
rs188692128	8	126,584,263	T	C	0.005	0.0017	3.589 (2.282–5.645)	1.278	0.231	3.13E-08	0.85	

